| Product Code: ETC13357134 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe AI in Drug Screening Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe AI in Drug Screening Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe AI in Drug Screening Market Revenues & Volume, 2021 & 2031F |
3.3 Europe AI in Drug Screening Market - Industry Life Cycle |
3.4 Europe AI in Drug Screening Market - Porter's Five Forces |
3.5 Europe AI in Drug Screening Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe AI in Drug Screening Market Revenues & Volume Share, By Market Type, 2021 & 2031F |
3.7 Europe AI in Drug Screening Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Europe AI in Drug Screening Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Europe AI in Drug Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Europe AI in Drug Screening Market Revenues & Volume Share, By Deployment Mode, 2021 & 2031F |
4 Europe AI in Drug Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe AI in Drug Screening Market Trends |
6 Europe AI in Drug Screening Market, 2021 - 2031 |
6.1 Europe AI in Drug Screening Market, Revenues & Volume, By Market Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe AI in Drug Screening Market, Revenues & Volume, By Preclinical Testing, 2021 - 2031 |
6.1.3 Europe AI in Drug Screening Market, Revenues & Volume, By Clinical Trials, 2021 - 2031 |
6.1.4 Europe AI in Drug Screening Market, Revenues & Volume, By Toxicity Prediction, 2021 - 2031 |
6.1.5 Europe AI in Drug Screening Market, Revenues & Volume, By Virtual Screening, 2020 - 2028 |
6.2 Europe AI in Drug Screening Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe AI in Drug Screening Market, Revenues & Volume, By Target Identification, 2021 - 2031 |
6.2.3 Europe AI in Drug Screening Market, Revenues & Volume, By Drug Repurposing, 2021 - 2031 |
6.2.4 Europe AI in Drug Screening Market, Revenues & Volume, By Lead Optimization, 2021 - 2031 |
6.2.5 Europe AI in Drug Screening Market, Revenues & Volume, By Biomarker Discovery, 2021 - 2031 |
6.3 Europe AI in Drug Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe AI in Drug Screening Market, Revenues & Volume, By Machine Learning, 2021 - 2031 |
6.3.3 Europe AI in Drug Screening Market, Revenues & Volume, By Deep Learning, 2021 - 2031 |
6.3.4 Europe AI in Drug Screening Market, Revenues & Volume, By Natural Language Processing (NLP), 2021 - 2031 |
6.3.5 Europe AI in Drug Screening Market, Revenues & Volume, By Computer Vision, 2021 - 2031 |
6.4 Europe AI in Drug Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe AI in Drug Screening Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.4.3 Europe AI in Drug Screening Market, Revenues & Volume, By Biotechnology Firms, 2021 - 2031 |
6.4.4 Europe AI in Drug Screening Market, Revenues & Volume, By Research Institutes, 2020 - 2028 |
6.4.5 Europe AI in Drug Screening Market, Revenues & Volume, By CROs, 2020 - 2028 |
6.5 Europe AI in Drug Screening Market, Revenues & Volume, By Deployment Mode, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Europe AI in Drug Screening Market, Revenues & Volume, By Cloud-Based, 2020 - 2028 |
6.5.3 Europe AI in Drug Screening Market, Revenues & Volume, By On-Premises, 2020 - 2028 |
6.5.4 Europe AI in Drug Screening Market, Revenues & Volume, By Hybrid, 2020 - 2028 |
6.5.5 Europe AI in Drug Screening Market, Revenues & Volume, By Edge, 2020 - 2028 |
7 Europe AI in Drug Screening Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe AI in Drug Screening Market, Revenues & Volume, By Market Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) AI in Drug Screening Market, Revenues & Volume, By Market Type, 2021 - 2031 |
7.2.2 Germany AI in Drug Screening Market, Revenues & Volume, By Market Type, 2021 - 2031 |
7.2.3 France AI in Drug Screening Market, Revenues & Volume, By Market Type, 2021 - 2031 |
7.2.4 Poland AI in Drug Screening Market, Revenues & Volume, By Market Type, 2021 - 2031 |
7.2.5 Spain AI in Drug Screening Market, Revenues & Volume, By Market Type, 2021 - 2031 |
7.2.6 Rest of Europe AI in Drug Screening Market, Revenues & Volume, By Market Type, 2021 - 2031 |
7.3 Europe AI in Drug Screening Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 United Kingdom (UK) AI in Drug Screening Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Germany AI in Drug Screening Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 France AI in Drug Screening Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.4 Poland AI in Drug Screening Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.5 Spain AI in Drug Screening Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.6 Rest of Europe AI in Drug Screening Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 Europe AI in Drug Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.1 United Kingdom (UK) AI in Drug Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.2 Germany AI in Drug Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.3 France AI in Drug Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.4 Poland AI in Drug Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.5 Spain AI in Drug Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.6 Rest of Europe AI in Drug Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5 Europe AI in Drug Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United Kingdom (UK) AI in Drug Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Germany AI in Drug Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 France AI in Drug Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.4 Poland AI in Drug Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.5 Spain AI in Drug Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.6 Rest of Europe AI in Drug Screening Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 Europe AI in Drug Screening Market, Revenues & Volume, By Deployment Mode, 2021 - 2031 |
7.6.1 United Kingdom (UK) AI in Drug Screening Market, Revenues & Volume, By Deployment Mode, 2021 - 2031 |
7.6.2 Germany AI in Drug Screening Market, Revenues & Volume, By Deployment Mode, 2021 - 2031 |
7.6.3 France AI in Drug Screening Market, Revenues & Volume, By Deployment Mode, 2021 - 2031 |
7.6.4 Poland AI in Drug Screening Market, Revenues & Volume, By Deployment Mode, 2021 - 2031 |
7.6.5 Spain AI in Drug Screening Market, Revenues & Volume, By Deployment Mode, 2021 - 2031 |
7.6.6 Rest of Europe AI in Drug Screening Market, Revenues & Volume, By Deployment Mode, 2021 - 2031 |
8 Europe AI in Drug Screening Market Key Performance Indicators |
9 Europe AI in Drug Screening Market - Export/Import By Countries Assessment |
10 Europe AI in Drug Screening Market - Opportunity Assessment |
10.1 Europe AI in Drug Screening Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe AI in Drug Screening Market Opportunity Assessment, By Market Type, 2021 & 2031F |
10.3 Europe AI in Drug Screening Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 Europe AI in Drug Screening Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.5 Europe AI in Drug Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
10.6 Europe AI in Drug Screening Market Opportunity Assessment, By Deployment Mode, 2021 & 2031F |
11 Europe AI in Drug Screening Market - Competitive Landscape |
11.1 Europe AI in Drug Screening Market Revenue Share, By Companies, 2022 |
11.2 Europe AI in Drug Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here